Unbound MEDLINE

Stability of amoxycillin and potassium clavulanate in co-amoxiclav oral suspension. Journal of clinical pharmacy and therapeutics. [J Clin Pharm Ther] Journal article

 
TitleStability of amoxycillin and potassium clavulanate in co-amoxiclav oral suspension.
Author(s)Mehta AC, Hart-Davies S, Payne J, Lacey RW 
InstitutionDepartment of Pharmacy, General Infirmary, Leeds, U.K.
SourceJ Clin Pharm Ther 1994 Oct; 19(5):313-5.
MeSHAmoxicillin
Amoxicillin-Potassium Clavulanate Combination
Chromatography, High Pressure Liquid
Clavulanic Acids
Drug Stability
Drug Therapy, Combination
Suspensions
Temperature
AbstractA study was carried out using high performance liquid chromatography (HPLC) to determine the chemical stability of amoxycillin and potassium clavulanate in 250/62 co-amoxyclav oral suspension (Augmentin), stored at room temperature (RT, 20 degrees C) and 8 degrees C over a period of 11 days. The suspension was judged to be acceptable if its components maintained at least 90% of their label concentrations. During the test period, the amoxycillin component was found to be more stable than the clavulanate. Amoxycillin was stable for 7 days at both temperatures. Potassium clavulanate maintained at least 90% of its initial concentration for 7 days at 8 degrees C but showed more than 40% degradation in the same time period at RT. For potassium clavulate the shelf-life, or time taken for the original concentration to drop to 90% of its value (t90) at RT was found to be 2 days.
Languageeng
Pub Type(s)Journal Article
PubMed ID7806602
  
Advertise on this site.